Inloggad som:
Cloudin-6 BNT211-01
Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.
Cloudin-6 BNT211-01
Phase I/IIa, first-in-human, open-label, dose escalation trial with expansion cohorts to evaluate safety and preliminary efficacy of CLDN6 CAR-T with or without CLDN6 RNA-LPX in patients with CLDN6-positive relapsed or refractory advanced solid tumors
Phase I/IIa, first-in-human, open-label, dose escalation trial with expansion cohorts to evaluate safety and preliminary efficacy of CLDN6 CAR-T with or without CLDN6 RNA-LPX in patients with CLDN6-positive relapsed or refractory advanced solid tumors
PLACEHOLDER
Mer information om studien för vårdgivare
Studien ändrades senast av: studysonia (2023-06-09)